Imugene Limited
Imugene Limited (IUGNF) Revenue
Annual & quarterly revenue history · segment & region breakdown
IUGNF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsImugene Limited trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Imugene Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Imugene Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Imugene Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IUGNF revenue · 4 questionsIUGNF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Imugene Limited SEC filings · GAAP · Imugene Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026